Table 2.

Proton-pump inhibitor dispensing prevalence in 2015 by sex and age (%)

	< 16	16–24	25–44	45–64	> 65	Total
Men
Omeprazole	0.29	2.40	6.77	16.89	47.73	14.60
Pantoprazole	0.00	0.04	0.21	0.66	2.13	0.59
Lansoprazole	0.01	0.05	0.12	0.49	1.27	0.38
Rabeprazole	0.00	0.02	0.06	0.18	0.51	0.15
Esomeprazole	0.04	0.06	0.23	0.48	1.03	0.38
Total	0.32	2.53	7.19	18.23	51.36	15.69
Women
Omeprazole	0.31	3.56	7.99	20.04	53.13	19.00
Pantoprazole	0.01	0.10	0.26	0.84	2.02	0.73
Lansoprazole	0.01	0.09	0.13	0.67	1.74	0.59
Rabeprazole	0.00	0.01	0.08	0.28	0.69	0.24
Esomeprazole	0.01	0.13	0.22	0.73	1.27	0.53
Total	0.33	3.78	8.42	21.73	57.18	20.43
All
Omeprazole	0.30	2.96	7.35	18.40	50.78	16.78
Pantoprazole	0.01	0.07	0.23	0.75	2.06	0.66
Lansoprazole	0.01	0.07	0.13	0.58	1.54	0.48
Rabeprazole	0.00	0.02	0.07	0.23	0.61	0.20
Esomeprazole	0.03	0.09	0.23	0.60	1.17	0.45
Total	0.33	3.13	7.77	19.91	54.64	18.04